Impact of heart failure on the behavior of human neonatal stem cells in vitro

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Klose, Kristin ^a   Roy, Rajika ^a   Brodarac, Andreja ^a   Kurtz, Andreas ^a   Ode, Andrea ^a   Kang, Kyung Sun ^b   Bieback, Karen ^c   Choi, Yeong Hoon ^d   Stamm, Christof ^a,e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Cord blood; Heart failure; Human; Mesenchymal stromal cells; Proliferation; Serum

Indexed keywords

BROXURIDINE; CASPASE 3; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN P21; PROTEIN P27; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD ANALYSIS; CELL COUNT; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL METABOLISM; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; CLONAL VARIATION; COLONY FORMING UNIT F; CONTROLLED STUDY; CORD BLOOD MESENCHYMAL STEM CELL; CULTURE MEDIUM; DISEASE SEVERITY; FEMALE; FETAL CALF SERUM; G1 PHASE CELL CYCLE CHECKPOINT; HEART FAILURE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL CYCLE; CELL PROLIFERATION; CLONE CELLS; COLONY-FORMING UNITS ASSAY; CYTOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FETAL BLOOD; HEART FAILURE; HUMANS; INFANT, NEWBORN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; SERUM; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84884638957     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-236     Document Type: Article

References (23)

1. Stamm C, Nasseri B, Drews T, Hetzer R. Cardiac cell therapy: a realistic concept for elderly patients?. Exp Gerontol 2008, 43:679-690. 10.1016/j.exger.2008.05.008, 18603395.
2. Wang X, Takagawa J, Lam VC, Haddad DJ, Tobler DL, Mok PY, Zhang Y, Clifford BT, Pinnamaneni K, Saini SA, et al. Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response. Sci Transl Med 2011, 3:100ra-190ra.
3. Dimmeler S, Leri A. Aging and disease as modifiers of efficacy of cell therapy. Circ Res 2008, 102:1319-1330. 10.1161/CIRCRESAHA.108.175943, 2728476, 18535269.
4. van Kimmenade RR, Januzzi JL. Emerging biomarkers in heart failure. Clin Chem 2012, 58:127-138. 10.1373/clinchem.2011.165720, 22086968.
5. Yamahara K, Min KD, Tomoike H, Kangawa K, Kitamura S, Nagaya N. Pathological role of angiostatin in heart failure: an endogenous inhibitor of mesenchymal stem-cell activation. Heart 2009, 95:283-289.
6. Gatta L, Armani A, Iellamo F, Consoli C, Molinari F, Caminiti G. Volterrani M 2010, Rosano GM: Effects of a short-term exercise training on serum factors involved in ventricular remodelling in chronic heart failure patients. Int J Cardiol.
7. Bieback K, Kluter H. Mesenchymal stromal cells from umbilical cord blood. Curr Stem Cell Res Ther 2007, 2:310-323. 10.2174/157488807782793763, 18220915.
8. Guder WG. Diagnostic samples: from the patient to the laboratory; the impact of preanalytical variables on the quality of laboratory results 2009, Wiley-Blackwell: Weinheim.
9. Bieback K, Kern S, Kluter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004, 22:625-634. 10.1634/stemcells.22-4-625, 15277708.
10. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317. 10.1080/14653240600855905, 16923606.
11. Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, Rozen SG. Primer3-new capabilities and interfaces. Nucleic Acids Res 2012, 40:e115. 10.1093/nar/gks596, 3424584, 22730293.
12. Miller L. ImageJ gel analysis http://www.lukemiller.org/ImageJ_gel_analysis.pdf.
13. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007, 167:989-997. 10.1001/archinte.167.10.989, 17533201.
14. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, Martin H, Zeiher AM, Dimmeler S. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004, 109:1615-1622. 10.1161/01.CIR.0000124476.32871.E3, 15037527.
15. Shahdadfar A, Fronsdal K, Haug T, Reinholt FP, Brinchmann JE. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 2005, 23:1357-1366. 10.1634/stemcells.2005-0094, 16081661.
16. Neef K, Choi YH, Weichel A, Rahmanian PB, Liakopoulos OJ, Stamm C, Choi CY, Jacobshagen C, Wittwer T, Wahlers T. The influence of cardiovascular risk factors on bone marrow mesenchymal stromal cell fitness. Cytotherapy 2012, 14:670-678.
17. Lucchinetti E, Awad AE, Rahman M, Feng J, Lou PH, Zhang L, Ionescu L, Lemieux H, Thebaud B, Zaugg M. Antiproliferative effects of local anesthetics on mesenchymal stem cells: potential implications for tumor spreading and wound healing. Anesthesiology 2012, 116:841-856. 10.1097/ALN.0b013e31824babfe, 22343474.
18. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, Benes V, Blake J, Pfister S, Eckstein V, Ho AD. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 2008, 3:e2213. 10.1371/journal.pone.0002213, 2374903, 18493317.
19. Walenda T, Bokermann G, Jost E, Galm O, Schellenberg A, Koch CM, Piroth DM, Drescher W, Brummendorf TH, Wagner W. Serum after autologous transplantation stimulates proliferation and expansion of human hematopoietic progenitor cells. PLoS One 2011, 6:e18012. 10.1371/journal.pone.0018012, 3060918, 21437259.
20. Mammi C, la Sala A, Volterrani M, Gatta L, Antelmi A, Feraco A, Caminiti G, Marazzi G, Vitale C, Caprio M, Rosano GM. Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure. Eur J Heart Fail 2011, 13:642-650. 10.1093/eurjhf/hfr026, 21613428.
21. Roucou X, Martinou JC. Conformational change of Bax: a question of life or death. Cell Death Differ 2001, 8:875-877. 10.1038/sj.cdd.4400910, 11526442.
22. Hommes DW, Peppelenbosch MP, van Deventer SJ. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 2003, 52:144-151. 10.1136/gut.52.1.144, 1773518, 12477778.
23. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N, Liedtke S, Sorg RV, Fischer J, Rosenbaum C, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004, 200:123-135. 10.1084/jem.20040440, 2212008, 15263023.